Benjamin M E, Hansen K J, Craven T E, Keith D R, Plonk G W, Geary R L, Dean R H
Department of General Surgery, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA.
Ann Surg. 1996 May;223(5):555-65; discussion 565-7. doi: 10.1097/00000658-199605000-00011.
This retrospective study examines results with simultaneous aortic and renal artery repair in 133 consecutive hypertensive patients. These results are compared with consecutive patient groups undergoing aortic reconstruction alone (269 patients) or renal artery reconstruction alone (182 patients).
From January 1987 through July 1995, 61 women and 72 men (mean age, 62.5 years) underwent combined repair of renal artery and aortic disease (abdominal aortic aneurysm [AAA]: 47 patients; occlusive disease: 86 patients; both: 12 patients). All patients were hypertensive (mean blood pressure: 194/103 mmHg; mean medications: 2.4). Evidenced by serum creatinine levels > or = 2.0 mg/dL, 46 patients (35%) had significant renal dysfunction (mean serum creatinine level: 3.78 mg/dL; range 2.0-10.6 mg/dL, including 7 dialysis-dependent patients). Aortic replacements (29% tube grafts; 71% bifurcated grafts) were combined with unilateral renal artery repair in 47% of patients; 53% had bilateral repair. Preoperative clinical features and perioperative mortality were compared with those groups having isolated aortic and renal repairs.
There were seven perioperative deaths (5.3%) after combined repair, which differed significantly from isolated aortic repair (mortality: 0.74%; p = 0.005), but did not reach statistical significance when compared with the isolated renal artery group (mortality: 1.65%; p = 0.145). Risk analysis did not reveal a significant association between preoperative clinical features and mortality in either the combined repair group or the groups undergoing renal repair alone or aortic repair alone. Among survivors in the combined group, a favorable hypertension response was observed in 63%. This differed significantly from the group receiving renal repair alone (90% cured/improved; p < 0.001). Based on a 20% decrease in serum creatinine levels, excretory renal function was improved in 33% of patients with combined repair, including four of the seven patients removed from hemodialysis. There were eight late deaths in the combined group.
Our experience suggest that contemporary perioperative mortality for combined aortic and renal repair has improved compared with earlier reports; however, perioperative mortality for simultaneous reconstruction remains greater than repair of aortic disease alone. Moreover, a lower rate of favorable hypertension response was observed after combined correction compared with renal artery repair alone. These differences suggest that aortic and renal artery repair should only be combined for clinical indications rather than for prophylactic repair of clinically silent disease.
本回顾性研究调查了133例连续性高血压患者同时进行主动脉和肾动脉修复的结果。将这些结果与单独进行主动脉重建(269例患者)或单独进行肾动脉重建(182例患者)的连续性患者组进行比较。
1987年1月至1995年7月,61名女性和72名男性(平均年龄62.5岁)接受了肾动脉和主动脉疾病的联合修复(腹主动脉瘤[AAA]:47例患者;闭塞性疾病:86例患者;两者皆有:12例患者)。所有患者均患有高血压(平均血压:194/103 mmHg;平均用药数量:2.4种)。血清肌酐水平≥2.0 mg/dL表明,46例患者(35%)存在显著肾功能不全(平均血清肌酐水平:3.78 mg/dL;范围2.0 - 10.6 mg/dL,包括7例依赖透析的患者)。47%的患者进行主动脉置换(29%为管状移植物;71%为分叉移植物)并联合单侧肾动脉修复;53%的患者进行双侧修复。将术前临床特征和围手术期死亡率与单纯进行主动脉和肾动脉修复的组进行比较。
联合修复后有7例围手术期死亡(5.3%),与单独进行主动脉修复(死亡率:0.74%;p = 0.005)有显著差异,但与单独进行肾动脉修复组(死亡率:1.65%;p = 0.145)相比未达到统计学意义。风险分析未发现联合修复组或单独进行肾动脉修复组或单独进行主动脉修复组中术前临床特征与死亡率之间存在显著关联。联合组幸存者中,63%观察到高血压反应良好。这与单独接受肾动脉修复的组有显著差异(90%治愈/改善;p < 0.001)。基于血清肌酐水平降低20%,联合修复的患者中有33%的患者排泄肾功能得到改善,包括7例接受血液透析的患者中有4例。联合组有8例晚期死亡。
我们的经验表明,与早期报告相比,当代主动脉和肾动脉联合修复的围手术期死亡率有所改善;然而,同时重建的围手术期死亡率仍高于单纯修复主动脉疾病。此外,与单独进行肾动脉修复相比,联合矫正后观察到的良好高血压反应率较低。这些差异表明,主动脉和肾动脉修复仅应在有临床指征时联合进行,而不应为临床无症状疾病进行预防性修复。